ARA-290 Product Description
ARA-290 is a non-erythropoietic peptide derived from erythropoietin, designed to retain the tissue-protective and anti-inflammatory properties of erythropoietin without its hematopoietic effects. This makes ARA-290 a promising candidate for research in various medical conditions where inflammation and tissue damage are prevalent.
One of the key areas of interest is its potential in treating neuropathic pain and metabolic disorders. In patients with type 2 diabetes, ARA-290 has shown promise in improving metabolic control and alleviating neuropathic symptoms, suggesting a role in both metabolic and nerve health.
Peptide Information
| Value |
|---|
| pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser |
| C51H84N16O21 |
| 1257.3 g/mol |
| 1208243-50-8 |
| 91810664 |
| Cibinetide, 1208243-50-8, ARA290, PHBSP, ARA 290 |
ARA-290 Structure
Source PubChem
